17 Mar 2025

2025 February NorthStar Monthly Report

2025 February NorthStar Monthly Report We are pleased to share our February 2025 report for the NorthStar Impact Australian
Continue Reading »
19 Feb 2025

2025 January NorthStar Monthly Report

2025 January NorthStar Monthly Report We are pleased to share our January 2025 report for the NorthStar Impact Australian
Continue Reading »
14 Jan 2025

2024 December NorthStar Monthly Report

2024 December NorthStar Monthly Report We are pleased to share our December 2024 report for the NorthStar Impact Australian
Continue Reading »
11 Dec 2024

Impact Report 2024: Highlights

Impact Report 2024: Highlights We’re pleased to share our Impact Report 2024 Highlights. Our impact report demonstrates our approach
Continue Reading »
31 Jul 2023

Genex Releases June 2023 Quarterly Report

Genex's June quarterly report shows encouraging positive operating cashflow and a strong solar revenue.
Continue Reading »
26 Jul 2023

UniSuper awards mandate to NorthStar Impact

UniSuper, the award-winning over $120bn super fund, has appointed NorthStar Impact as a specialist external listed equities manager.
Continue Reading »
13 Oct 2022

Botanix delivers clinically meaningful results in its BTX 1702 Phase 1b/2 clinical study

Botanix Pharmaceuticals has announced its BTX 1702 Phase 1b/2 clinical study on papulopustular rosacea has produced clinically meaningful data. 
Continue Reading »
12 Oct 2022

Volpara Receives B Corp Certification

Volpara Health Technologies (“Volpara”), which provides clinically validated software for the early detection of breast cancer, has been certified
Continue Reading »
« Previous Page